Inventor
ZABLOCKI JEFF A
US24 patents
⚠️ This page may combine multiple inventors who share the name “ZABLOCKI JEFF A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CV THERAPEUTICS INC
15 patentsUS6403567B1Jun 11, 2002
N-pyrazole A2A adenosine receptor agonists
CV THERAPEUTICS INC112 citations99
US6605597B1Aug 12, 2003
Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
CV THERAPEUTICS INC97 citations98
US7553823B2Jun 30, 2009
C-pyrazole A2A receptor agonists
CV THERAPEUTICS INC48 citations96
US7144872B2Dec 5, 2006
N-pyrazole A2A receptor agonists
CV THERAPEUTICS INC50 citations96
US7109180B2Sep 19, 2006
C-pyrazole A2A receptor agonists
CV THERAPEUTICS INC43 citations96
US6770634B1Aug 3, 2004
C-pyrazole a2a receptor agonists
CV THERAPEUTICS INC46 citations96
US6642210B1Nov 4, 2003
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
CV THERAPEUTICS INC61 citations96
US6294522B1Sep 25, 2001
N6 heterocyclic 8-modified adenosine derivatives
CV THERAPEUTICS INC122 citations96
US6214807B1Apr 10, 2001
C-pyrazole 2A A receptor agonists
CV THERAPEUTICS INC74 citations96
US6548548B2Apr 15, 2003
ABCA-1 elevating compounds
CV THERAPEUTICS INC61 citations95
US6440948B1Aug 27, 2002
Thiophene A2A receptor agonists
CV THERAPEUTICS INC19 citations92
US6180615B1Jan 30, 2001
Propargyl phenyl ether A2A receptor agonists
CV THERAPEUTICS INC26 citations92
US6258793B1Jul 10, 2001
N6 heterocyclic 5′ modified adenosine derivatives
CV THERAPEUTICS INC21 citations83
US6576619B2Jun 10, 2003
Orally active A1 adenosine receptor agonists
CV THERAPEUTICS INC4 citations56
US6995285B2Feb 7, 2006
ABCA-1 elevating compounds
CV THERAPEUTICS INC1 citations51
GILEAD SCIENCES INC
3 patentsUSRE47351EApr 16, 2019
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
GILEAD SCIENCES INC5 citations73
US9045519B2Jun 2, 2015
N-pyrazole A2A receptor agonists
GILEAD SCIENCES INC2 citations63
US9416115B2Aug 16, 2016
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC0 citations52